CytoMed Therapeutics Limited (GDTC) Drug Pipeline

The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness

A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.

GDTC is currently developing the following drugs: Allogeneic Nkg2dl-Targeting Chimeric Antigen Receptor-Grafted Γδ T Cells (Ctm-N2d). These drug candidates are in various stages of clinical development as the company works toward FDA approval.